SPP1 and ovarian carcinoma: More recently, Guo et al. validated two of these biomarkers and demonstrated that the combination OPN, MIF, CA-125 and anti-IL-8 autoantibodies was able to increase detection of ovarian cancer compared to CA125 alone [13].